Literature DB >> 9821011

The emergence of triglycerides as a significant independent risk factor in coronary artery disease.

G Assmann1, H Schulte, H Funke, A von Eckardstein.   

Abstract

The Prospective Cardiovascular Münster (PROCAM) study involved 4849 middle-aged men who were followed up for 8 years to record the incidence of coronary heart disease (CHD) events according to the risk factors present at study entry. The study showed that fasting levels of triglycerides were an independent risk factor for CHD events, irrespective of serum levels of high density lipoprotein cholesterol (HDL-C) or low density lipoprotein cholesterol (LDL-C). Other independent predictors of CHD included serum levels of LDL-C and HDL-C, age, systolic blood pressure, cigarette smoking, diabetes mellitus, a family history of myocardial infarction and angina pectoris, but did not include total serum cholesterol levels. Individuals with an LDL-C/HDL-C ratio > 5 had a 19.2% chance of experiencing a CHD event in the next 8 years. Furthermore, if an LDL-C/HDL-C ratio > 5 was combined with hypertriglyceridaemia (> or = 2.3 mmol. l-1), the risk of CHD increased to 26.9%. The association between hypertriglyceridaemia and CHD events may be related to the presence of atherogenic, triglyceride-rich particles in plasma, such as LDL and very low density lipoproteins. High triglyceride levels may also predispose to thrombosis. Individuals with potentially atherogenic lipid profiles should be managed initially through the introduction of lifestyle changes. However, if these fail to achieve recommended target values, lipid-lowering therapy should be considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821011

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  48 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Goals of statin therapy: three viewpoints.

Authors:  Gilbert R Thompson; Christopher J Packard; Neil J Stone
Journal:  Curr Atheroscler Rep       Date:  2002-01       Impact factor: 5.113

Review 3.  The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors:  Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

4.  Richard Havel, Howard Eder, and the evolution of lipoprotein analysis.

Authors:  Scott M Grundy
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 5.  Management strategies of dyslipidemia in the elderly: 2005.

Authors:  Tarek Helmy; Amar D Patel; Fadi Alameddine; Nanette K Wenger
Journal:  MedGenMed       Date:  2005-10-10

6.  Prevalence of metabolic syndrome in turkmen ethnic groups in gorgan.

Authors:  Najmeh Shahini; Iman Shahini; Abdoljalal Marjani
Journal:  J Clin Diagn Res       Date:  2013-09-10

7.  Fibrates for primary prevention of cardiovascular disease events.

Authors:  Alain J Nordmann; Ignacio Ferreira-González; Benjamin Kasenda; Ramon Saccilotto; Dirk Bassler; Neera Bhatnagar; Matthias Briel
Journal:  Cochrane Database Syst Rev       Date:  2012

8.  Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.

Authors:  Jonathan Isaacsohn; Donald Hunninghake; Helmut Schrott; Carlos A Dujovne; Robert Knopp; Stuart R Weiss; Harold Bays; John R Crouse; Michael H Davidson; Leonard M Keilson; James McKenney; Stanley G Korenman; Adrian S Dobs; Evan Stein; Ronald M Krauss; Darbie Maccubbin; Meehyung Cho; Diane J Plotkin; Yale B Mitchel
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

9.  Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.

Authors:  Ayman A Hussein; Stephen J Nicholls
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

10.  Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial.

Authors:  Una Bradley; Michelle Spence; C Hamish Courtney; Michelle C McKinley; Cieran N Ennis; David R McCance; Jane McEneny; Patrick M Bell; Ian S Young; Steven J Hunter
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.